Your browser doesn't support javascript.
loading
Oncogenes and Methionine Addiction of Cancer: Role of c-MYC.
Aoki, Yusuke; Han, Qinghong; Kubota, Yutaro; Masaki, Noriyuki; Obara, Koya; Tome, Yasunori; Bouvet, Michael; Nishida, Kotaro; Hoffman, Robert M.
Afiliação
  • Aoki Y; AntiCancer Inc, San Diego, CA, U.S.A.; all@anticancer.com yastome@med.u-ryukyu.ac.jp yaoki0630@gmail.com.
  • Han Q; Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.
  • Kubota Y; Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Masaki N; AntiCancer Inc, San Diego, CA, U.S.A.
  • Obara K; AntiCancer Inc, San Diego, CA, U.S.A.
  • Tome Y; Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.
  • Bouvet M; AntiCancer Inc, San Diego, CA, U.S.A.
  • Nishida K; Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.
  • Hoffman RM; AntiCancer Inc, San Diego, CA, U.S.A.
Cancer Genomics Proteomics ; 20(2): 165-170, 2023.
Article em En | MEDLINE | ID: mdl-36870694
BACKGROUND/AIM: Methionine addiction is a general and fundamental hallmark of cancer cells, termed the Hoffman effect. Previously Vanhamme and Szpirer showed that methionine addiction could be induced by transfection of the activated HRAS1 gene to a normal cell line. In the present study, we investigated the role of the c-MYC oncogene in methionine addiction of cancer, by comparison of c-Myc expression and malignancy of methionine-addicted osteosarcoma cells and rare methionine-independent revertants, derived from the methionine-addicted cells. MATERIALS AND METHODS: Methionine-independent revertant 143B osteosarcoma cells (143B-R) were derived from methionine-addicted parental 143B osteosarcoma cells (143B-P), by continuous culture in medium depleted of methionine by recombinant methioninase. To compare in vitro malignancy of methionine-addicted parental cells and methionine-independent revertant cells, the following experiments were performed: for 143B-P and 143B-R cells, cell proliferation capacity was measured with a cell-counting assay, and colony-formation capacity was determined on plastic and in soft agar, all in methionine-containing Dulbecco's Modified Eagle's Medium (DMEM). Tumor growth was measured in orthotopic xenograft nude-mouse models, to compare in vivo malignancy of 143B-P and 143B-R cells. c-MYC expression was examined with western immunoblotting and compared in 143B-P and 143B-R cells. RESULTS: 143B-R cells had reduced cell proliferation capacity, compared to 143B-P cells, in methionine-containing medium (p=0.003). 143B-R cells had reduced colony formation capacity on plastic (p=0.003) and in soft agar, compared to 143B-P cells in methionine-containing medium. 143B-R cells had reduced tumor growth in orthotopic xenograft nude-mouse models, compared to 143B-P cells, (p=0.002). These results demonstrate that 143B-R methionine-independent revertant cells lost malignancy. Expression of c-MYC was reduced in 143B-R methionine-independent revertant osteosarcoma cells, compared to 143B-P cells, (p=0.0007). CONCLUSION: The present study demonstrated that c-MYC expression is linked to malignancy and methionine addiction of cancer cells. The present study on c-MYC, and the previous study on HRAS1, suggest that oncogenes may play a role in methionine addiction, which is a hallmark of all cancers, as well as in malignancy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article